Genistein promotion of osteogenic differentiation through BMP2/SMAD5/RUNX2 signaling

International Journal of Biological Sciences

Volumn 9, Issue 10, 2013, Pages 1089-1098

  Dai, Jin ^a,b   Li, Yalin ^b,d   Zhou, Honghao ^b   Chen, Jie ^a   Chen, Minhu ^a   Xiao, Zhousheng ^c  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Central South University   (China)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cell; CDNA microarray; Genistein; Osteogenic differentiation

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; GENISTEIN; PRIMER DNA; RUNX2 PROTEIN, HUMAN; SMAD5 PROTEIN; SMAD5 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; ARTICLE; BONE; CDNA MICROARRAY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENISTEIN, BONE MARROW MESENCHYMAL STEM CELL; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; OSTEOGENIC DIFFERENTIATION; REAL TIME POLYMERASE CHAIN REACTION;

CDNA MICROARRAY; GENISTEIN, BONE MARROW MESENCHYMAL STEM CELL; OSTEOGENIC DIFFERENTIATION;

APOPTOSIS; BASE SEQUENCE; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENISTEIN; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SMAD5 PROTEIN;

EID: 84904239960     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7367     Document Type: Article

References (57)

1. Liberman UA, Weiss SR, Bröll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995;333(22):1437-43.
2. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9(8):1137-41.
3. Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 1997;12(4):498-508.
4. Järvinen TL, Kannus P, Sievänen H. Estrogen and bone--a reproductive and locomotive perspective. J Bone Miner Res 2003;18(11):1921-31.
5. Michaëlsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ 1998;316(7148):1858-63.
6. Blank RD, Bockman RS. A review of clinical trials of therapies for osteoporosis using fracture as an end point. J Clin Densitom 1999;2(4):435-52.
7. Recker RR. Clinical review 41: Current therapy for osteoporosis. J Clin Endocrinol Metab 1993;76(1):14-6.
8. Vihtamäki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999;33(2):99-105.
9. Toth S, Blanchard E, Herman L, et al. Weighing the risks and benefits of hormone therapy. JAAPA 2003;16(6):45-7.
10. Rickard DJ, Monroe DG, Ruesink TJ, et al. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem 2003;89(3):633-46.
11. Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996;17(2):271-5.
12. Wang H-J, Murphy PA. Isoflavone Composition of American and Japanese Soybeans in Iowa: Effects of Variety, Crop Year, and Location. Journal of Agricultural and Food Chemistry 1994;42(8):1674-77.
13. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. Journal of Nutrition 1996;126(1):161-67.
14. Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 2001;24(4):368-72.
15. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002;17(10):1904-12.
16. D'Anna R, Cannata ML, Marini H, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause 2009;16(2):301-6.
17. Atteritano M, Marini H, Minutoli L, et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007;92(8):3068-75.
18. D'Anna R, Cannata ML, Atteritano M, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 2007;14(4):648-55.
19. Ross PD, Norimatsu H, Davis JW, et al. A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991;133(8):801-9.
20. Fujita T, Fukase M. Comparison of osteoporosis and calcium intake between Japan and the United States. Proc Soc Exp Biol Med 1992;200(2):149-52.
21. Kin K, Lee JH, Kushida K, et al. Bone density and body composition on the Pacific rim: a comparison between Japan-born and U.S.-born Japanese-American women. J Bone Miner Res 1993;8(7):861-9.
22. Liao QC, Xiao ZS, Qin YF, Zhou HH. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture. Acta Pharmacol Sin 2007;28(10):1597-602.
23. Pan W, Quarles LD, Song LH, et al. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J Cell Biochem 2005;94(2):307-16.
24. Chen X, Garner SC, Quarles LD, Anderson JJ. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem 2003;14(6):342-9.
25. Heim M, Frank O, Kampmann G, et al. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004;145(2):848-59.
26. Okumura N, Yoshikawa T, Iida J, Nonomura A, Takakura Y. Bone formation-promoting effect of genistein on marrow mesenchymal cell culture. Biomed Mater Eng 2006;16(1):23-32.
27. Dai Z, Li Y, Quarles LD, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 2007;14(12):806-14.
28. Abdallah BM, Haack-Sorensen M, Burns JS, et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 2005;326(3):527-38.
29. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176(1):57-66.
30. Pereira RF, O'Hara MD, Laptev AV, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 1998;95(3):1142-7.
31. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7.
32. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000;105(12):1663-8.
33. Yu YY, Lieu S, Lu C, Colnot C. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 2010;47(1):65-73.
34. Ghodadra N, Singh K. Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biologics 2008;2(3):345-54.
35. Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 2011;35(9):1271-80.
36. Carpenter RS, Goodrich LR, Frisbie DD, et al. Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone. J Orthop Res 2010;28(10):1330-7.
37. Seib FP, Franke M, Jing D, Werner C, Bornhauser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol 2009;88(5):257-71.
38. Zhou S, Turgeman G, Harris SE, et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol 2003;17(1):56-66.
39. Hertrampf T, Gruca MJ, Seibel J, et al. The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity. Bone 2007;40(6):1529-35.
40. Ma HP, Ming LG, Ge BF, et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem 2011;112(3):916-23.
41. Plant A, Tobias JH. Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration. J Bone Miner Res 2002;17(5):782-90.
42. Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene 2005;357(1):1-8.
43. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999;25(1):91-3.
44. Retting KN, Song B, Yoon BS, Lyons KM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009;136(7):1093-104.
45. Rath B, Nam J, Deschner J, et al. Biomechanical forces exert anabolic effects on osteoblasts by activation of SMAD 1/5/8 through type 1 BMP receptor. Biorheology 2011;48(1):37-48.
46. Ishida W, Hamamoto T, Kusanagi K, et al. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 2000;275(9):6075-9.
47. Fujii M, Takeda K, Imamura T, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 1999;10(11):3801-13.
48. Fried A, Benayahu D, Wientroub S. Marrow stroma-derived osteogenic clonal cell lines: putative stages in osteoblastic differentiation. J Cell Physiol 1993;155(3):472-82.
49. Shindo K, Kawashima N, Sakamoto K, et al. Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling. Exp Cell Res 2003;290(2):370-80.
50. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89(5):755-64.
51. Xiao G, Gopalakrishnan R, Jiang D, et al. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17(1):101-10.
52. Suzawa M, Takeuchi Y, Fukumoto S, et al. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 1999;140(5):2125-33.
53. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000;20(23):8783-92.
54. Bae JS, Gutierrez S, Narla R, et al. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. J Cell Biochem 2007;100(2):434-49.
55. Fakhry A, Ratisoontorn C, Vedhachalam C, et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 2005;36(2):254-66.
56. Aberg T, Wozney J, Thesleff I. Expression patterns of bone morphogenetic proteins (Bmps) in the developing mouse tooth suggest roles in morphogenesis and cell differentiation. Dev Dyn 1997;210(4):383-96.
57. Morsczeck C, Gotz W, Schierholz J, et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol 2005;24(2):155-65.